Cyclo Therapeutics, Inc. (CYTH) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 25.96M |
| Enterprise Value | 17.75M |
| P/E Ratio | -0.59 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 21.92 |
| Price/Book Ratio | 2.47 |
| Enterprise/Revenue | 14.28 |
| Enterprise/EBITDA | -0.77 |
| Fiscal Year | December 31, 2023 |
| Most Recent Quarter | September 30, 2024 |
| Profit Margin | -18.63 |
| Operating Margin | -18.63 |
| Return On Assets | -1.51 |
| Return On Equity | -7.3 |
| Revenue | 1.08M |
| Revenue/Share | 0.07 |
| Gross Profit | 977,947 |
| EBITDA | -20.03M |
| Net Income | -20.06M |
| Diluted EPS | -1.23 |
| Total Cash | 928,010 |
| Total Cash/Share | 0.57 |
| Total Debt | 12.21M |
| Total Debt/Equity | 0.22 |
| Current Ratio | 1.45 |
| Book Value Per Share | 0.29 |
| 52-Week Change | -44.14 |
| 52-Week High | 1.62 |
| 52-Week Low | 0.55 |
| Moving Average 50 Days | 0.8 |
| Moving Average 200 Days | 0.83 |
| Average Volume | 1.76M |
| Shares Outstanding | 32.74M |
| % Held by Institutions | 7.87 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
| Last Split Date | December 09, 2020 |